2 weeks ago
Lord's Mark Industries Gets Licence for Gut Microbiome Analytics Platform
A company in India called Lord's Mark Industries has received a licence for a new kind of health test.
The test is called Biomescan and it looks at the tiny organisms living in your stomach, known as the gut microbiome.
Your gut is home to trillions of these tiny organisms, which help with digestion and staying healthy.
The test uses special computer analysis to understand your gut and suggest what foods might be good for you.
The company wants to help people stay healthy before they get sick, instead of only treating sickness later.
They plan to open 3,000 health centres across India in the next three years.
The company also thinks the test might help with questions about having babies, but scientists have not proven that yet.
The company's leader says healthcare should focus on preventing problems, not just fixing them.
Lord's Mark Industries Limited received a manufacturing licence for its Biomescan Analytics Platform from the Maharashtra State Licensing Authority.
The platform analyzes gut microbiomes using whole metagenome sequencing data and a bioinformatics pipeline, providing diversity scores, enterotype classification and dietary recommendations.
India's gut health supplements market is valued at USD 565.51 million in 2025 and projected to reach USD 1,619.56 million by 2034, at a CAGR of 11.07%.
The company plans to set up 3,000 Health & Wellness Centres across India over the next three years and launch app-based services.
Biomescan is licensed as a wellness and health-information tool, not for standalone clinical diagnosis; its fertility-related insights lack independently verified scientific evidence.
- Who
- Lord's Mark Industries Limited, led by Managing Director Sachidanand Upadhyay, and the Maharashtra State Licensing Authority.
- What
- The company received a manufacturing licence for Biomescan Analytics Platform, an In Vitro Diagnostic Software (Software as a Medical Device) that analyzes gut microbiomes for personalized wellness insights.
- Where
- India; the licence was provided by the Maharashtra State Licensing Authority.
- When
- No specific date is provided; the licence announcement coincides with India's gut health supplements market being valued at USD 565.51 million in 2025 and projected to reach USD 1,619.56 million by 2034.
- Why
- To position the company among early movers in preventive healthcare by enabling early gut microbiome-based risk identification and personalized nutrition.
Company View
Verification Concerns
Gut testing for fertility
Company View
Lord's Mark Industries says gut microbiome testing may also offer insights relevant to fertility-related concerns, an area it plans to focus on going forward.
Verification Concerns
Hindustan Times could not independently obtain clinical or scientific evidence supporting gut microbiome testing as a validated tool for fertility assessment.
Key facts
- Company
- Lord's Mark Industries Limited
- Product
- Biomescan Analytics Platform (In Vitro Diagnostic Software / SaMD)
- Licensing Authority
- Maharashtra State Licensing Authority
- Market Size (2025)
- USD 565.51 million
- Projected Market (2034)
- USD 1,619.56 million
- Market CAGR
- 11.07%
- Planned Health & Wellness Centres
- 3,000 centres in India over three years
- Platform Status
- Wellness and health-information tool; not for standalone clinical diagnosis
Quotes
Sachidanand Upadhyay
Managing Director of Lord’s Mark Industries Ltd.
“"Healthcare is moving from reactive treatment to proactive prevention. Our vision is to empower every individual with scientific insights into their own health before disease develops."”
livemint.com
Sources
Related news
Lord's Mark Industries Gets India's First Gut Microbiome Analytics License
World of Microbiome 2026 Highlights Precision Health In Bengaluru
Lord's Mark Industries Unveils ₹1,550 Crore Healthcare Expansion Plan
Brilliance Cosmocare Raises $200,000 Seed Round for Longevity Skin Platform
SynbioTech to Showcase TWK10® in GLP-1 Nutrition Market
Lord’s Mark Plans Healthcare Expansion, Revenue Growth and Energy Demerger
Lord’s Mark and ARKALL Plan Healthcare Expansion Across Caribbean